Awani Review

Complete News World

En mars, des tests de contrôle avaient déjà révélé que 15 millions de doses du vaccin de Johnson&Johnson avaient été gâchées dans cette usine gérée par l’entreprise Emergent BioSolutions.

United States – Sixty million unusable amount

Published

At a factory in Baltimore (USA), the products of the two vaccines were mistakenly mixed. Verdict: Johnson & Johnson’s 60 million dose will be destroyed.

Control tests in March already revealed that 15 million doses of Johnson & Johnson vaccine had been wasted at the plant, which is managed by Emergency Bio Solutions..

AFP

Production of “several volumes” of the Johnson & Johnson’s Govt-19 vaccine, manufactured at the Baltimore plant, had to be stopped several weeks ago, U.S. health officials said Friday. According to the “New York Times”, the results are estimated at 60 million units.

Control tests in March already revealed that 15 million doses of Johnson & Johnson vaccine had been wasted at the plant, which is managed by partner Emergent Bio Solutions. In addition to the “J&J” vaccine, it was also manufactured in AstraZeneca, and the products that enter the second mix are mistakenly mixed with the first, contaminating these 15 million doses that make them unusable.

Two lots passed

These quantities were never allowed to be distributed to the factory, officials at the time promised. The U.S. Medicines Agency (FDA) then sent experts to the site and inspected the premises and the remaining quantities.

On Friday, the FDA finally gave the green light to “two batches” of Johnson & Johnson vaccines manufactured at the plant that could be “exported to the United States or overseas.” This equates to tens of millions, according to a source familiar with the matter.

Others are being explored

On the contrary, he said, “the FDA has determined that many places cannot be used.” These 60 million levels will have to be thrown away. “Additional locations are still being explored,” the FDA said.

Production of the Astrogeneka solution has been permanently withdrawn from the plant, and Johnson & Johnson vaccine has been suspended there pending a decision by health officials. The FDA said Friday it was “not yet ready to resume production” and continued to “work on issues” with officials at Johnson & Johnson & Emerging Bio Solutions.

Amount given to backward countries?

In addition, at least 60 million doses of this factory-produced astrogen gene are still waiting to send green light from the FDA. A total of 80 million doses are expected to be delivered by the end of June, and the U.S. administration has promised to donate these amounts to vulnerable countries, mostly via the Kovacs sharing device.

(AFP)

See also  DGAP-Adhoc: The Social Chain AG: Social Chain AG Successfully Plays Convertible Bond 2021/2024, Total Nominal Euro 25,000,000.00